Lower Respiratory Tract Infection Treatment Market, By Drug Class (Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others), By Disease Indication (Upper Respiratory Tract Infection and Lower Respiratory Tract Infection), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI483721 | Publish Date: August 2023 | No. of Pages: 198

Global Lower Respiratory Tract Infection Treatment Market Overview

Bronchitis, asthma, allergic rhinitis, pneumonia, and sinusitis are all respiratory illnesses that can considerably limit an individual's physical activities. Coughing, wheezing, chest pain, respiratory distress, shortness of breath, congestion, and even mortality are symptoms linked with both moderate and severe indications of various respiratory disorders. These disorders generate significant morbidity and impose a significant financial burden on society. As a result, the development of new pharmaceuticals with fewer side effects for the treatment of respiratory tract infection is a major issue for manufacturers, given the large number of generic players on the market, which account for the vast majority of market share. Lower respiratory tract infection refers to infection that occurs below the level of the larynx. Lower respiratory tract illness is frequently referred to as pneumonia. These illnesses are not all classified the same way, but flu, bronchitis, bronchiolitis, and pneumonia are among the most common. Viruses such as adenoviruses, coronaviruses, parainfluenza virus, rhinoviruses, and bacteria such as Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae can all cause illness. Infections of the lower respiratory tract are the primary cause of illness and mortality in both children and adults around the world.

Global Lower Respiratory Tract Infection Treatment Market Dynamics

Rising prevalence of chronic respiratory disorders will drive the growth of the Market

The rising prevalence of chronic respiratory disorders such asthma, chronic pulmonary fibrosis, pulmonary hypertension, and occupational lung disease are driving the respiratory tract infection market forward. Asthma and chronic obstructive pulmonary disease (COPD), for example, are common chronic obstructive lung disorders characterised by variable airflow limitation and airway hyperresponsiveness, affecting over 25 million people in the United States, according to the Biomed Central Respiratory Research.

Various organisations, institutions, and agencies are collaborating to improve diagnostic and medical care in order to lessen the worldwide burden of respiratory disorders. For example, the World Health Organization (WHO) supported the formation of the Global Alliance against Chronic Respiratory Diseases (GARD) to combat chronic respiratory diseases. GARD's major goal is to develop easy and affordable chronic respiratory disease (CRD) strategies, as well as to urge economies to implement health promotion and CRD prevention policies.

The presence of several medications in the pipeline, which are projected to be released throughout the forecast period, would also help the respiratory tract infection treatment market grow. Relenza (GSK), MK7264 (Merck & Co.), Presatovir (Gilead), AZD7594, and PT010 are some of the medications in development (AstraZeneca).

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Lower Respiratory Tract Infection Treatment Market Segmentation

 

                                    Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The Global Lower Respiratory Tract Infection Treatment Market is segmented based on drug class, disease indication, distribution channel and region.

On the basis of Drug Class, the Global Lower Respiratory Tract Infection Treatment Market is segmented into Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others. Based on Disease Indication, the target market is segmented into Upper Respiratory Tract Infection and Lower Respiratory Tract Infection. Based on Distribution Channel, the target market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

Regional Insights:

                                                                        Source: Prophecy Market Insights

                               

On region the Global Lower Respiratory Tract Infection Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The existence of several generic manufacturers and the low cost of various medications, including antibiotics, in the market, however, may limit the respiratory tract infection treatment market to some amount over the projection period. Because of the rising number of hospitalizations and emergency visits associated with acute or life-threatening medical conditions, North America is likely to have a dominating position in the worldwide respiratory tract infection treatment market over the forecast period. According to a research published by the Society of Critical Care Medicine, more than 5.7 million patients are admitted to intensive care units (ICUs) in the United States each year for airway, breathing, or circulatory support.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Drug Class- Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others

By Disease Indication– Upper Respiratory Tract Infection and Lower Respiratory Tract Infection

By Distribution Channel- Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Lower Respiratory Tract Infection Treatment Market report based on drug class, disease indication, distribution channel, and region.

Global Lower Respiratory Tract Infection Treatment Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Lower Respiratory Tract Infection Treatment Market Key Players

The key players operating in the lower respiratory tract infection treatment market are Abbott Laboratories, AstraZeneca, Plc, Abbvie Inc., Boehringer Ingelheim GmbH, Cipla Pharmaceutical Company, GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Novartis AG, F. Hoffman La Roche Ltd, Sanofi, and Teva Pharmaceutical Industries Ltd.

Global Lower Respiratory Tract Infection Treatment Market Company Profile

  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca, Plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbvie Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cipla Pharmaceutical Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck & Co.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global Lower Respiratory Tract Infection Treatment Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for lower respiratory tract infection treatment Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Drug Class
      • Market Snippet, By Disease Indication
      • Market Snippet, By Distribution Channel
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Lower Respiratory Tract Infection Treatment Market, By Drug Class, 2020 – 2030, (US$ Mn)                                                          
    • Overview         
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Antibiotics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cough Suppressant
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Nasal Decongestant
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Lower Respiratory Tract Infection Treatment Market, By Disease Indication, 2020 – 2030, (US$ Mn)
    • Overview                                                 
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Upper Respiratory Tract Infection
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Lower Respiratory Tract Infection
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Autonomous Vehicle
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Lower Respiratory Tract Infection Treatment Market, By Distribution Channel, 2020 – 2030, (US$ Mn)
    • Overview                                   
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Online Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Lower Respiratory Tract Infection Treatment Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Indication, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Indication, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Indication, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Indication, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Indication, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca, Plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbvie Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cipla Pharmaceutical Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck & Co.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Global Lower Respiratory Tract Infection Treatment Market is segmented based on drug class, disease indication, distribution channel and region.

Rising prevalence of chronic respiratory disorders is major factor driving the market.

During the forecast period, North America is expected to dominate the market.

The key players operating in the lower respiratory tract infection treatment market are Abbott Laboratories, AstraZeneca, Plc, Abbvie Inc., Boehringer Ingelheim GmbH, Cipla Pharmaceutical Company, GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Novartis AG, F. Hoffman La Roche Ltd, Sanofi, and Teva Pharmaceutical Industries Ltd.